hero image
 Dr. Michael  Farkouh - University Health Network. Toronto, ON, CA

Dr. Michael Farkouh  Dr. Michael  Farkouh

Clinical Researcher | University Health Network

Toronto, ON, CANADA

Dr. Farkouh's areas of research include: evaluation of chest pain syndromes, diabetes and heart diseases






International Academy of Cardiology: Michael E. Farkouh, M.D.: DESIGN OF FUTURE REVASCULARIZATION International Academy of Cardiology: Michael Farkouh, M.D.: A LARGE PRAGMATIC TRIAL Michael Farkouh, MD, Talks about the Prevention of Diabetes Mellitus International Academy of Cardiology: Michael Farkouh, M.D.: MEDICAL RISK FACTOR CONTROL IN LARGE Dr. Michael Farkouh - J. Allyn Taylor International Prize in Medicine Symposium 2013




Dr. Farkouh has designed and conducted numerous pivotal clinical trials including: CHEER (Chest Pain Evaluation in the Emergency Room), TARGET, STATUS and FREEDOM (enrolling). His areas of research include: evaluation of chest pain syndromes, diabetes and heart diseases and the relationship of anti-inflammatory agents and heart disease. Dr. Farkouh is the PI for the BARI 2D and TRIUMPH trials at Mount Sinai. His past appointments include director of the telemetry unit at Mount Sinai, director of the cardiac care unit at New York University and director of the Electrocardiography Core Laboratory at the Cardiovascular Research Foundation. He has been awarded Teacher of the Year in the Department of Medicine at the Mayo Clinic. Dr. Farkouh has been an invited speaker internationally and served on numerous data safety monitoring boards. - See more at: http://www.mountsinai.org/profiles/michael-e-farkouh#sthash.8QDxKJo6.dpuf

Industry Expertise (3)

Health and Wellness

Medical Devices

Medical/Dental Practice

Areas of Expertise (7)

Cardiovascular Disease


Clinical Trials



High Blood Pressure

Acute Coronary Syndrome

Education (3)

Mount Sinai: Cardiovascular Fellowship 1998

University of Western Ontario: M.D. 1988

McMaster University: M.Sc., Edpidemiology

Affiliations (1)

  • Mount Sinai Hospital

Languages (1)

  • English

Media Appearances (4)

Q&A With Michael Farkouh From the University of Toronto: Monitoring Blood Pressure and Stroke Risk in Bypass Patients

HCP LIve  


Michael Farkouh, MD, MSc, from the University of Toronto discussed a recent study that was done looking at this topic during the European Society of Cardiology's annual conference in London...

view more

Registry Data Challenge CABG Survival Advantage in Diabetics vs PCI Using Contemporary Stents

MedScapr Multispeciality  


Dr Michael Farkouh (University of Toronto, ON), who led the FREEDOM trial along with Dr Valentin Fuster (Icahn School of Medicine at Mount Sinai, New York), said he has a "real skepticism" that the newer-generation stents can close the mortality gap between CABG and PCI over the long term. The registry analysis, he said, is too short to differentiate a long-term benefit of CABG over PCI...

view more

Medications used to treat diabetes may trigger heart failure, study finds



"While some drugs showed an increased risk, other strategies tested, such as intensi​ve weight loss to control blood sugar, showed a trend towards a lower risk for heart failure," says Dr. Michael Farkouh, senior author of the study and Chair, Peter Munk Centre of Excellence in Multinational Clinical Trials, where the study was conducted...

view more

The timeline of any new drug begins with a clinical trial

Toronto Star  


Led by Michael Farkouh, PMCC cardiologist and international expert in cardiovascular prevention and how it relates to other medical conditions including diabetes...

view more

Articles (5)

The Management of Acute Chest Pain: What Lies Beyond the Emergency Department Doors? Journal of the American College of Cardiology


(ED) visits annually in the United States and a reported 2% of patients discharged from the ED with a missed acute coronary syndrome, the optimal management of acute chest pain in the ED is a dilemma faced by many clinicians (1). Risk stratification on the basis of the ...

view more

Long-term outcome of PCI versus CABG in insulin and non–insulin-treated diabetic patients: results from the FREEDOM trial Journal of the American College of Cardiology


The prospective, randomized FREEDOM (Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes) trial found coronary artery bypass graft surgery (CABG) was associated with better clinical outcomes than ...

view more

Risk factor control for coronary artery disease secondary prevention in large randomized trials Journal of the American College of Cardiology


This study evaluated data from 3 federally funded trials that focused on optimal medical therapy to determine if formalized attempts at risk factor control within clinical trials are effective in achieving guideline-driven treatment goals for diabetic patients with ...

view more

Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials The Lancet Diabetes & Endocrinology


The choice between coronary artery bypass surgery (CABG) and percutaneous coronary intervention (PCI) for revascularisation in patients with diabetes and multivessel coronary artery disease, who account for 25% of revascularisation procedures, is much ...

view more

Strategies for multivessel revascularization in patients with diabetes New England Journal of Medicine


In some randomized trials comparing revascularization strategies for patients with diabetes, coronary-artery bypass grafting (CABG) has had a better outcome than percutaneous coronary intervention (PCI). We sought to discover whether aggressive ...

view more